Dalterio S, Bartke A, Brodie A, Mayfield D
J Steroid Biochem. 1983 Apr;18(4):391-6. doi: 10.1016/0022-4731(83)90056-0.
These studies determined the local acute responsiveness of the testis to intratesticular administration of human chorionic gonadotropin (hCG) under basal, stimulated (systemic hCG pre-treated), hypogonadotropic (steroid pre-treatment) and hyperprolactinemic conditions in male mice. In addition, testicular testosterone (T) levels were determined after intratesticular administration of the aromatase inhibitor, 4-hydroxyandrostenedione (4-OHA) or progesterone under basal or hCG-stimulated conditions. Intratesticular administration of 0.025, 0.25, 2.5 or 25 mIU hCG resulted in a dose-dependent (3- to 14-fold) increase in testicular T concentrations in hCG compared to vehicle-injected testes. Systemic (i.p.) pre-treatment with 5 IU hCG 24 h before prevented any further increases in the already elevated (10-fold basal) T levels after direct intratesticular hCG injection. Pretreatment with 250 micrograms testosterone propionate (TP) reduced basal testicular T concentrations, but resulted in increased responsiveness to intratesticular hCG administration. In contrast, estradiol benzoate (EB) pretreatment, which also reduced basal testicular T concentrations, did not affect the testicular responsiveness to hCG. Hyperprolactinemia reduced testicular responsiveness to intratesticular administration of 0.025, 0.25 or 2.5 mIU hCG, but basal levels of testicular T were elevated. One hour after intratesticular injections of an aromatase inhibitor, 4-OHA; (0.25 micrograms) testis, T levels were increased in males pre-treated with 5 IU hCG (i.p.) 24 h earlier. Higher doses of 4-OHA (2.5, 25 or 250 micrograms) resulted in significant, dose-related increases in basal testicular T levels which were attenuated by hCG-pre-treatment. Intratesticular administration of 20 micrograms progesterone increased testicular T concentrations 2.7-fold, but this effect was attenuated (1.5-fold) in hCG-pre-treated mice, suggesting that enzymatic lesions beyond progesterone may be involved in hCG-induced testicular desensitization. These results indicate that testicular responsiveness to hCG depends on the existing levels of gonadotropic stimulation. However, it is evident that estrogens and prolactin also influence the sensitivity of the testis to gonadotropin.
这些研究确定了在基础、刺激(全身hCG预处理)、低促性腺激素(类固醇预处理)和高催乳素血症条件下,雄性小鼠睾丸对睾丸内注射人绒毛膜促性腺激素(hCG)的局部急性反应性。此外,在基础或hCG刺激条件下,睾丸内注射芳香化酶抑制剂4-羟基雄烯二酮(4-OHA)或孕酮后,测定睾丸睾酮(T)水平。与注射赋形剂的睾丸相比,睾丸内注射0.025、0.25、2.5或25 mIU hCG导致hCG组睾丸T浓度呈剂量依赖性(3至14倍)增加。在直接睾丸内注射hCG前24小时用5 IU hCG进行全身(腹腔内)预处理,可防止已经升高(基础水平的10倍)的T水平进一步升高。用250微克丙酸睾酮(TP)预处理可降低基础睾丸T浓度,但导致对睾丸内注射hCG的反应性增加。相比之下,苯甲酸雌二醇(EB)预处理虽然也降低了基础睾丸T浓度,但不影响睾丸对hCG的反应性。高催乳素血症降低了睾丸对睾丸内注射0.025、0.25或2.5 mIU hCG的反应性,但睾丸T的基础水平升高。在睾丸内注射芳香化酶抑制剂4-OHA(0.25微克)1小时后,24小时前用5 IU hCG(腹腔内)预处理的雄性小鼠睾丸T水平升高。更高剂量的4-OHA(2.5、25或250微克)导致基础睾丸T水平显著、剂量相关地增加,而hCG预处理可减弱这种增加。睾丸内注射20微克孕酮可使睾丸T浓度增加2.7倍,但在hCG预处理的小鼠中这种作用减弱(1.5倍),这表明除孕酮外的酶损伤可能参与了hCG诱导的睾丸脱敏。这些结果表明,睾丸对hCG的反应性取决于促性腺激素刺激的现有水平。然而,很明显雌激素和催乳素也会影响睾丸对促性腺激素的敏感性。